Among the comutations of NPM1mut AML, TET2(+) was identified as an independent factor predicting lower cCR rate and inferior EFS in the NPM1mut/FLT3‐ITD(−) group, consistent with other results.28, 29. Here, FLT3 is linked to acute myeloid leukemia.